Heron Therapeutics
HRTX
#7580
Rank
A$0.43 B
Marketcap
$2.88
Share price
0.00%
Change (1 day)
-31.61%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.83. In 2022 the company made an earnings per share (EPS) of -$2.71 an increase over its 2021 EPS that were of -$3.53.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-34.96%
2022-$2.71-23.11%
2021-$3.53-10%
2020-$3.92-0%
2019-$3.921.21%
2018-$3.87-32.7%
2017-$5.75-19.34%
2016-$7.1354.76%
2015-$4.611.73%
2014-$4.53-16.23%
2013-$5.4191.67%
2012-$2.82-31.45%
2011-$4.12-27.06%
2010-$5.64-43.75%
2009-$10.03-57.33%
2008-$23.52-82.92%
2007-$137.6620.61%
2006-$114.14175.76%
2005-$41.39-21.43%
2004-$52.68100%
2003-$26.34-38.24%
2002-$42.64161.54%
2001-$16.31-106.46%
2000$252.252051.55%
1999$11.72839.73%
1998$1.25-105.48%
1997-$22.78-88.16%
1996-$192.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.04-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.22-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.56 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.46-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.59 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA